NM_000094.4:c.2242G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000094.4(COL7A1):​c.2242G>A​(p.Glu748Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 1,613,730 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 43 hom. )

Consequence

COL7A1
NM_000094.4 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.947

Publications

11 publications found
Variant links:
Genes affected
COL7A1 (HGNC:2214): (collagen type VII alpha 1 chain) This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. [provided by RefSeq, Jul 2008]
COL7A1 Gene-Disease associations (from GenCC):
  • epidermolysis bullosa with congenital localized absence of skin and deformity of nails
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dystrophic epidermolysis bullosa pruriginosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • recessive dystrophic epidermolysis bullosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, ClinGen
  • generalized dominant dystrophic epidermolysis bullosa
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
  • pretibial dystrophic epidermolysis bullosa
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • transient bullous dermolysis of the newborn
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • acral dystrophic epidermolysis bullosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dystrophic epidermolysis bullosa, nails only
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa inversa
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa-generalized other
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011641651).
BP6
Variant 3-48589399-C-T is Benign according to our data. Variant chr3-48589399-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00149 (227/152304) while in subpopulation SAS AF = 0.0151 (73/4828). AF 95% confidence interval is 0.0123. There are 1 homozygotes in GnomAd4. There are 131 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 43 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL7A1NM_000094.4 linkc.2242G>A p.Glu748Lys missense_variant Exon 18 of 119 ENST00000681320.1 NP_000085.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL7A1ENST00000681320.1 linkc.2242G>A p.Glu748Lys missense_variant Exon 18 of 119 NM_000094.4 ENSP00000506558.1
COL7A1ENST00000328333.12 linkc.2242G>A p.Glu748Lys missense_variant Exon 17 of 118 1 ENSP00000332371.8

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
227
AN:
152186
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00438
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0151
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00109
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00319
AC:
801
AN:
250884
AF XY:
0.00408
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00145
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00149
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00183
AC:
2670
AN:
1461426
Hom.:
43
Cov.:
36
AF XY:
0.00241
AC XY:
1753
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33480
American (AMR)
AF:
0.00112
AC:
50
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000880
AC:
23
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0184
AC:
1585
AN:
86256
European-Finnish (FIN)
AF:
0.0000189
AC:
1
AN:
52976
Middle Eastern (MID)
AF:
0.0141
AC:
81
AN:
5762
European-Non Finnish (NFE)
AF:
0.000683
AC:
760
AN:
1112002
Other (OTH)
AF:
0.00267
AC:
161
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
230
460
690
920
1150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00149
AC:
227
AN:
152304
Hom.:
1
Cov.:
32
AF XY:
0.00176
AC XY:
131
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41542
American (AMR)
AF:
0.00438
AC:
67
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.0151
AC:
73
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00109
AC:
74
AN:
68020
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00131
Hom.:
3
Bravo
AF:
0.00108
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00330
AC:
400
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.00218
EpiControl
AF:
0.00296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epidermolysis bullosa dystrophica Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
1.9
L
PhyloP100
0.95
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.62
N
REVEL
Benign
0.19
Sift
Benign
0.23
T
Sift4G
Benign
0.14
T
Polyphen
0.96
D
Vest4
0.49
MVP
0.82
MPC
0.28
ClinPred
0.016
T
GERP RS
5.3
Varity_R
0.098
gMVP
0.30
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148411473; hg19: chr3-48626832; API